Roche said it will acquire biopharmaceutical company Poseida Therapeutics in a deal worth up to $1.5 billion. The pharmaceutical company said Tuesday that it has entered into a definitive merger ...

Roche Holding said a late-stage clinical trial that studied the effectiveness of a combination of drugs to treat lung cancer didn't reach its primary goal.

Quarterly net interest income was a weaker-than-expected 3.11 billion ringgit, down from 3.17 billion ringgit a year ago, while its noninterest income jumped 21% to 2.34 billion ringgit. Net ...